Skip to main content
. 2015 May 13;10(5):e0126347. doi: 10.1371/journal.pone.0126347

Fig 3. Risks of all types of cardiovascular diseases associated with non-steroidal anti-inflammatory drugs (NSAIDs).

Fig 3

(A) Total NSAIDs, (B) specific cyclooxygenase II (COX II) inhibitors, (C) non-selective NSAIDs. NSAID exposure was categorized into non-users, MPR<80% and MPR≥80%. The data were adjusted by the CCI and other drugs used.